Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period

ClinicalTrials.gov ID: NCT06108544

Public ClinicalTrials.gov record NCT06108544. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 8:57 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Multicenter, Double-Blind, Placebo- and Active Comparator-Controlled Study With a Randomized Withdrawal and Retreatment Period to Evaluate the Efficacy, Safety, and Tolerability of TAK-279 in Subjects With Moderate-to-Severe Plaque Psoriasis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The main aim of this study is to show how well TAK-279 reduces the skin plaques compared to placebo, in participants with moderate-to-severe plaque psoriasis. Participants will be assigned to one of the 3 study treatments (TAK-279, apremilast (an approved treatment), or a placebo). Participants will be in the study for up to 69 weeks.

Study identification

NCT ID
NCT06108544
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Takeda
Industry
Enrollment
1,108 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 6, 2023 (Actual)
Primary completion
Dec 6, 2024 (Actual)
Completion
Nov 7, 2025 (Actual)
Last update posted
Nov 20, 2025

2023 – 2025

United States locations

U.S. sites
66
U.S. states
26
U.S. cities
57
Facility City State ZIP Site status
Total Dermatology Birmingham Alabama 35205 —
Cahaba Dermatology Skin Health Center Hoover Alabama 35244-2111 —
Medical Dermatology Specialists Phoenix Arizona 85006-2722 —
Noble Clinical Research Tucson Arizona 85704-7892 —
Johnson Dermatology Clinic Fort Smith Arkansas 72916-6103 —
Burke Pharmaceutical Research Hot Springs Arkansas 71913-6475 —
Zenith Research, Inc. Beverly Hills California 90211-1705 —
UNISON Clinical Trials (Shahram Jacobs md inc.) Encino California 91436-2428 —
First OC Dermatology Research Inc. Fountain Valley California 92708-3701 —
Long Beach Research Institute, LLC Long Beach California 90805-4587 —
Metropolis Dermatology Downtown LA - Probity - PPDS Los Angeles California 90017-5310 —
Northridge Clinical Trials Northridge California 91325-4122 —
TCR Medical Corporation San Diego California 92123-1523 —
University Clinical Trials San Diego California 92123 —
Dermatology Institute and Skin Care Center Santa Monica California 90404-2216 —
Revival Research Corporation - Florida - ClinEdge - PPDS Doral Florida 33122-1902 —
Florida Academic Centers Research Miami Florida 33136-1003 —
San Marcus Research Clinic Inc Miami Lakes Florida 33014-5602 —
FXM Research Miramar Miramar Florida 33027-4714 —
Lenus Research & Medical Group Sweetwater Florida 33172-2741 —
Advanced Clinical Research Institute (ACRI) - Florida Tampa Florida 33607-6429 —
Olympian Clinical Research - 6331 Memorial Hwy Tampa Florida 33615 —
Divine Dermatology and Aesthetics, LLC Atlanta Georgia 30315-2042 —
Advanced Medical Research, PC Atlanta Georgia 30342-1418 —
Skin Care Physicians of Georgia Macon Georgia 31217-3861 —
NorthShore Medical Group Dermatology - Skokie Skokie Illinois 60077-1049 —
DS Research - 1005 E. Lewis & Clark Pkwy Indiana Location Clarksville Indiana 47129-2201 —
Skin Sciences, PLLC Louisville Kentucky 40217-1444 —
DS Research of Kentucky Louisville Kentucky 40241-6162 —
Dermatology & Advanced Aesthetics Lake Charles Louisiana 70605-1213 —
Lawrence J Green, MD LLC Rockville Maryland 20850-6363 —
Allcutis Research LLC Beverly Massachusetts 01915 —
Beacon Clinical Research LLC Brockton Massachusetts 02301 —
David Fivenson MD Dermatology PLLC Ann Arbor Michigan 48103-9746 —
University of Michigan Hospital - 1500 E Medical Center Dr Ann Arbor Michigan 48109-5360 —
Oakland Hills Dermatology - 3400 Auburn Rd Auburn Hills Michigan 48326-3396 —
Minnesota Clinical Study Center Fridley Minnesota 55432-3134 —
Skin Specialists PC Omaha Nebraska 68144 —
Vivida Dermatology - Flamingo Rd - Probity - PPDS Las Vegas Nevada 89119-5190 —
ALLCUTIS Research, LLC. Portsmouth New Hampshire 03801-03804 —
Psoriasis Treatment Center of Central New Jersey East Windsor New Jersey 08520 —
Mount Sinai Doctors -234 E 85th St New York New York 10029-6504 —
Sadick Research Group New York New York 10075-0385 —
Derm Research Center of NY Stony Brook New York 11790 —
Montefiore Dermatology - BRANY - PPDS The Bronx New York 10467-1402 —
Duke Dermatology Clinic Durham North Carolina 27710-4000 —
The Skin Surgery Center for Clinical Research - Objective Health - PPDS Winston-Salem North Carolina 27103-7109 —
Wake Forest Baptist Health Department of Dermatology - 4618 Country Club Rd Winston-Salem North Carolina 27157-0001 —
ClinOhio Research Services Columbus Ohio 43213-4445 —
Wright State Physicians Fairborn Ohio 45324 —
Apex Clinical Research Center Mayfield Heights Ohio 44124-4005 —
Oregon Medical Research Center PC Portland Oregon 97239-4501 —
University of Pittsburgh Medical Center-3601 5th Ave Pittsburgh Pennsylvania 15213-3403 —
Cumberland Skin Center for Clinical Research - Objective Health - PPDS Hermitage Tennessee 37076-3497 —
Tennessee Clinical Research Center Nashville Tennessee 37215-2888 —
Arlington Research Center Arlington Texas 76011-3800 —
UT Physicians Dermatology - Bellaire Station Bellaire Texas 77401-3535 —
Modern Research Associates Dallas Texas 75231-6077 —
North Texas Center for Clinical Research Frisco Texas 75034 —
Austin Institute for Clinical Research, Inc. - Pflugerville - ClinEdge - PPDS Pflugerville Texas 78660-6148 —
Texas Dermatology and Laser Specialists San Antonio Texas 78218-3128 —
Dermatology Clinical Research Center of San Antonio San Antonio Texas 78229-3409 —
Houston Center for Clinical Research, LLC Sugar Land Texas 77479-1001 —
Center For Clinical Studies, LTD. LLP - 451 N Texas Ave Webster Texas 77598-4927 —
Center For Clinical Studies,LTD. LLP - 451 N Texas Ave Webster Texas 77598-4927 —
Virginia Clinical Research - 6160 Kempsville Cir Norfolk Virginia 23507 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 151 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06108544, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 20, 2025 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06108544 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →